Latest news, press releases, and SEC filings for AstraZeneca PLC (AZN) https://caymanjournal.com/stock/AZN en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:01:06 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is a **Form 6-K**, a standard monthly report that foreign companies listed on U.S. exchanges (like AstraZeneca on the NYSE) must file with the SEC. It’s used to announce important company news to the public. This specific filing from **April 2026** contains one key an https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003818 https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003818 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing # 📜 What This Document Is 📰 This document is a Form 6-K, which is a report filed with the U.S. Securities and Exchange Commission (SEC) by a foreign private issuer. Simply put, it’s a detailed update designed to keep investors informed about major corporate events or clinical trial results that h https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003757 https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003757 Tue, 21 Apr 2026 00:00:00 GMT SEC Filing # 🧾 Form 6-K 📑 What This Document Is This document is a Form 6-K, which is a mandatory filing that allows AstraZeneca PLC, a foreign-listed company, to report major, timely updates to U.S. investors. Because it's an interim filing, it’s not a quarterly or annual report, but rather an announcement https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003703 https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003703 Mon, 20 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **Form 6-K**, a standard report that a foreign company listed on U.S. exchanges (like the London Stock Exchange) must file with the SEC. Think of it as an official news update for American investors. The big news here? AstraZeneca just held its **Annual General https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003374 https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003374 Thu, 09 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **Form 6-K**, a report foreign companies like AstraZeneca file with the SEC to share important news with U.S. investors. This specific report, dated April 2, 2026, is a press release announcing **positive results from a major Phase III clinical trial** called EME https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003206 https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003206 Thu, 02 Apr 2026 00:00:00 GMT SEC Filing # 🔖 What This Document Is This is a **Form 6-K**, a standard monthly report that foreign companies listed in the U.S. must file with the SEC. Think of it as a routine update from AstraZeneca to its American investors. This specific filing contains two official notifications required by UK regulator https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003157 https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003157 Wed, 01 Apr 2026 00:00:00 GMT SEC Filing # 🔖 What This Document Is This is a **Form 6-K**, a report that foreign companies listed on U.S. exchanges (like AstraZeneca) use to quickly release material news to the market. This specific filing, dated March 31, 2026, is a clinical trial results announcement. It contains "inside information," m https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003013 https://caymanjournal.com/stock/AZN/sec-filing/0001654954-26-003013 Tue, 31 Mar 2026 00:00:00 GMT SEC Filing